LFS is a rare hereditary cancer predisposition disease. This condition is associated with the development of various malignant tumors, even in the CNS. We reported a case of 16-monthold female patient with ACC who developed an expansive right parietal gliosarcoma at the age of 18. Gliosarcoma is a rare variant of glioblastoma multiforme. It is estimated to be present in approximately 2% of all glioblastomas with a dismal prognosis. Interestingly, TP53 gene analysis of our patient showed the germline mutation c.796G>A (p.Gly266Arg) in heterozygous. Germline TP53 mutations are responsible for a subset of metachronous malignancies in LFS patients. They are at risk for developing most common and rare brain tumors as gliosarcoma. A better knowledge of the tumors associated with LFS could help to identify individuals who should be tested for the presence of germline TP53 mutation. Moreover, the characterization of germline TP53 mutation in a family may consent an early identification of high-risk subjects and provide the basis for a correct surveillance with an appropriate long-life monitoring clinical and psychosocial program.

Brain tumors in Li-Fraumeni syndrome: a commentary and a case of a gliosarcoma patient

GIGLIO, SABRINA RITA
Membro del Collaboration Group
;
2017-01-01

Abstract

LFS is a rare hereditary cancer predisposition disease. This condition is associated with the development of various malignant tumors, even in the CNS. We reported a case of 16-monthold female patient with ACC who developed an expansive right parietal gliosarcoma at the age of 18. Gliosarcoma is a rare variant of glioblastoma multiforme. It is estimated to be present in approximately 2% of all glioblastomas with a dismal prognosis. Interestingly, TP53 gene analysis of our patient showed the germline mutation c.796G>A (p.Gly266Arg) in heterozygous. Germline TP53 mutations are responsible for a subset of metachronous malignancies in LFS patients. They are at risk for developing most common and rare brain tumors as gliosarcoma. A better knowledge of the tumors associated with LFS could help to identify individuals who should be tested for the presence of germline TP53 mutation. Moreover, the characterization of germline TP53 mutation in a family may consent an early identification of high-risk subjects and provide the basis for a correct surveillance with an appropriate long-life monitoring clinical and psychosocial program.
2017
Li-Fraumeni syndrome; TP53; Hereditary cancer predisposition; Germline mutation c.796G>A; Rare brain tumors; Correct surveillance
File in questo prodotto:
File Dimensione Formato  
3- Brain tumors in Li-Fraumeni syndrome-a commentary and a case of a gliosarcoma patient.pdf

Solo gestori archivio

Tipologia: versione post-print
Dimensione 1.06 MB
Formato Adobe PDF
1.06 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/298165
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 2
social impact